Clinical Trials on Ovarian Cancer, TNBC, SCLC, Other Solid Tumours
Total 1706 results
-
Novartis PharmaceuticalsTerminatedMelanoma | Ovarian Cancer | NSCLC | Other Solid TumorsItaly, Spain, Netherlands, France, Korea, Republic of, Switzerland, Germany, Japan, United States, Canada
-
AstraZenecaCompletedOvarian Cancer, TNBC, SCLC, Other Solid TumoursUnited States, Canada
-
National Cancer Institute (NCI)RecruitingSolid Tumor | Refractory Solid Tumors | Malignant Solid Tumors | Other Neoplasms Solid Tumors | Pediatric Solid TumorUnited States
-
ExelixisCompletedCancer | NSCLC | Solid TumorsJapan
-
PfizerCompletedBreast Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | NSCLC | Prostate Cancer | Advanced Solid Tumors | Solid TumorsUnited States, Australia
-
PfizerActive, not recruitingOvarian Cancer | NSCLC | Solid Tumors | Urothelial Cancer | Advanced MalignanciesHungary, Spain, United States, Canada, Taiwan, Japan, Serbia, Italy, New Zealand, Australia, Mexico, Russian Federation, United Kingdom, France, Korea, Republic of, Belgium, Poland, Denmark, Israel
-
Genentech, Inc.RecruitingMelanoma | Cervical Cancer | HCC | Gastric Cancer | Esophageal Cancer | NSCLC | Urothelial Carcinoma | HNSCC | Locally Advanced or Metastatic Solid Tumors | TNBC | Clear Cell RCCKorea, Republic of, Netherlands, Spain, United States, Australia, Canada, Belgium
-
Astellas Pharma Global Development, Inc.Seagen Inc.CompletedMetastatic Urothelial Cancer and Other Malignant Solid TumorsUnited States, Canada
-
AbbVieNo longer availableHigh Grade Serous Ovarian Cancer | Solid Tumors With Documented BRCA, BARD, or PALB or Other Acceptable DNA Mutations or Anomalies That Are Scientifically Sound | Triple Negative Breast Cancer (TNBC) | Patients Requiring Veliparib Suspension Formulation
-
AbbVieActive, not recruitingCancer | Advanced Solid Tumors | Metastatic Solid Tumors | Triple-Negative Breast Cancer (TNBC) | Non-small-cell-lung-cancer (NSCLC)United States, Australia, France, Israel, Spain, Taiwan
-
National Cancer Institute (NCI)RecruitingSCLC | Advanced Solid Tumor | Small Cell Cancer | High Grade Neuroendocrine CancersUnited States
-
Shanghai Kanda Biotechnology Co., Ltd.Not yet recruitingOther Solid Tumors | Advanced HCCChina
-
Jacobio Pharmaceuticals Co., Ltd.RecruitingNSCLC | AML | SCLC | Ovarian Carcinoma | Malignant Tumor | ESCC | CRPC | MFChina
-
Immatics US, Inc.CompletedCancer | Solid Tumor | Refractory Solid Tumors | Recurrent Solid TumorsUnited States, Germany
-
Laekna LimitedCompletedSolid Tumor | TNBC - Triple-Negative Breast CancerChina
-
Immix Biopharma Australia Pty LtdActive, not recruitingBreast Cancer | Pancreatic Cancer | Ovarian Cancer | Advanced Solid Tumors | Solid Tumor, AdultUnited States, Australia
-
AstraZenecaCompletedRefractory Solid Tumors | Cancer TumorUnited States
-
PharmaMarCompletedMajor Advanced Solid Tumors Other Than ColorectalUnited States
-
Daiichi Sankyo, Inc.CompletedAdvanced Solid Malignant Tumors | Advanced Ovarian CancerUnited States
-
National Cancer Institute (NCI)CompletedNSCLC | Solid Tumors | Lymphomas | Granulosa Cell Ovarian Cancer | Metastatic Colon CarcinomaUnited States
-
OncoResponse, Inc.RecruitingCancer | Metastatic Cancer | Advanced Solid Tumor | Platinum-resistant Ovarian Cancer | Malignant Neoplasm | Tumor, Solid | Cutaneous Squamous Cell CarcinomaUnited States
-
Jacobio Pharmaceuticals Co., Ltd.AbbVieRecruitingNSCLC | Solid TumorUnited States
-
Sichuan Baili Pharmaceutical Co., Ltd.SystImmune Inc.; Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.RecruitingOther Solid Tumors | Locally Advanced or Metastatic Digestive Tract TumorsChina
-
Calithera Biosciences, IncCompletedNSCLC | Solid Tumors | KRAS Gene Mutation | CRCUnited States
-
Navire Pharma Inc., a BridgeBio companyAmgenRecruitingNon Small Cell Lung Cancer | Metastatic Solid Tumor | Solid Tumor, Adult | Metastatic NSCLCSpain, Australia, France, Denmark, Greece, Italy, Netherlands
-
Xuanzhu Biopharmaceutical Co., Ltd.Not yet recruiting
-
Jacobio Pharmaceuticals Co., Ltd.RecruitingNSCLC | Solid Tumor | CRCChina
-
MediLink Therapeutics (Suzhou) Co., Ltd.RecruitingBreast Cancer | NSCLC | HNSCC | Locally Advanced or Metastatic Solid TumorsChina
-
Keystone Nano, IncNational Cancer Institute (NCI); National Institutes of Health (NIH)UnknownCarcinoma | Cancer | Solid Tumors | TumorUnited States
-
Shanghai Huaota Biopharmaceutical Co., Ltd.RecruitingNSCLC | Advanced Solid TumorUnited States, China
-
GlaxoSmithKlineCompleted
-
Jacobio Pharmaceuticals Co., Ltd.RecruitingNSCLC | Advanced Solid Tumor | CRCUnited States
-
Novartis PharmaceuticalsRecruitingContinued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid MalignanciesSpain, United States, Taiwan, Singapore, France
-
InventisBio Co., LtdMerck Sharp & Dohme LLCActive, not recruitingNSCLC | Solid Tumor, Adult | CRCUnited States, Taiwan, Australia, Korea, Republic of
-
Memorial Sloan Kettering Cancer CenterAstraZenecaRecruitingSolid Tumor | Metastatic Cancer | Metastatic Solid Tumor | Solid Tumor, Adult | Solid Carcinoma | Metastatic TumorUnited States
-
Jacobio Pharmaceuticals Co., Ltd.RecruitingSolid Tumors | ER+ Breast Cancer | ARID1A Gene Mutation | Triple Negative Breast Cancer, TNBC | Small Cell Lung Cancer, SCLCUnited States, China
-
Revolution Medicines, Inc.RecruitingNon-Small Cell Lung Cancer, NSCLC | KRAS, NRAS, HRAS-mutated NSCLC | KRAS G12C-mutated Solid Tumors, Lung Cancer | Lung Cancer Stage IV, Advanced Solid Tumor, CancerUnited States
-
National Cancer Institute (NCI)CompletedAdvanced Breast Cancer | Advanced Solid Tumors | Primary Peritoneal Cancer | Advanced Ovarian CancerUnited States
-
AGO Study GroupEssex Pharma GmbH; MedServ. GmbH, WiesbadenCompletedCervical Cancers | Cancer of the Ovary Treated as 2nd Line Therapy | Muellerian Mixed Tumours | Tumours of the Uterus | Non-Epithelial Ovarian TumoursGermany
-
Aadi Bioscience, Inc.RecruitingMalignant Solid Neoplasm | Neoplasms | Cancer | Neoplasm Metastasis | Solid Tumor | Metastatic Cancer | Metastasis | Advanced Solid Tumor | Metastatic Solid Tumor | Advanced Cancer | Tumor | Malignant Neoplasm | Malignant Tumor | Tumors | Cancer Metastatic | Tumor, Solid | Malignant Solid Tumor | TSC | TSC1 | TSC2 | Metastatic NeoplasmKorea, Republic of, United States, Puerto Rico
-
AstraZenecaCompletedRefractory Solid Tumours | Relapsed Small Cell Lung Cancer (SCLC)United States, Canada
-
Semafore PharmaceuticalsSignalRX Pharmaceuticals, Inc.CompletedCancer | Advanced or Metastatic Solid Tumors | Solid CancersUnited States
-
Iqvia Pty LtdTerminatedCancer - Solid TumoursAustralia
-
AmgenCompletedCancer | Advanced Solid Tumors | Solid Tumors | Tumors | Advanced MalignancyUnited States, Australia
-
NantCell, Inc.CompletedQUILT-2.016: Study of AMG 479 With Biologics or Chemotherapy for Subjects With Advanced Solid TumorsCancer | Advanced Solid Tumors | Solid Tumors | Tumors | Advanced Malignancy
-
Merck Sharp & Dohme LLCCompletedAdvanced Breast Cancer | Other Solid Tumors
-
Laminar PharmaceuticalsRoyal Marsden NHS Foundation Trust; Vall d'Hebron Institute of Oncology; Specialized... and other collaboratorsCompletedGlioma | Other Solid TumoursSpain, United Kingdom
-
Astellas Pharma Global Development, Inc.CompletedOvarian Cancer | NSCLC | Solid Tumors | ESCCUnited States
-
National University Hospital, SingaporeNot yet recruitingOther Solid Tumors | HER2+ Advanced Breast Cancer
-
JS InnoPharm, LLCRecruiting